DUPHASTON

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DUPHASTON contains one active pharmaceutical ingredient (API):

1 Dehydroprogesterone UNII 90I02KLE8K - DYDROGESTERONE

Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone. Read about Dehydroprogesterone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DUPHASTON Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DB01	Dydrogesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DB Pregnadien derivatives
Discover more medicines within G03DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500214100033217, 500214100033307
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00542072, 00542089, 01682786, 03904587, 16596727, 16838544
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29426-10-10
Country: EE	Ravimiamet	Identifier(s): 1054752, 1529344
Country: FR	Base de données publique des médicaments	Identifier(s): 64866204
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39417
Country: HK	Department of Health Drug Office	Identifier(s): 32067
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-511623868
Country: IE	Health Products Regulatory Authority	Identifier(s): 22818
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8190
Country: JP	医薬品医療機器総合機構	Identifier(s): 2478003F1031
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006243, 1051319, 1054622, 1067933, 1070168, 1075480, 1078899
Country: MT	Medicines Authority	Identifier(s): MA1507/00601, PI1438/03501A, PI908/03301A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 110M2006
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 906
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100100891, 100239637, 100254128, 100260940, 100278896, 100283466, 100290503, 100324389, 100327933, 100336524, 100339089, 100348450, 100348622, 100358448, 100393189, 100431843, 100436480, 100438779, 100440084, 100453600
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69083001, W69083002
Country: SG	Health Sciences Authority	Identifier(s): 11255P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 22843011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699820010065
Country: ZA	Health Products Regulatory Authority	Identifier(s): S/21.8.2/165